| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.015 | 0.9 |